Review: taking Claritin and Midol together


Summary

Drug interactions are reported among people who take Claritin and Midol together. This review analyzes the effectiveness and drug interactions between Claritin and Midol. It is created by eHealthMe based on reports of 3,238 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 38,013 users)

Midol

Midol has active ingredients of ibuprofen. It is often used in dysmenorrhoea. (latest outcomes from Midol 1,666 users)

On Sep, 19, 2016

3,238 people who take Claritin, Midol are studied.


Number of reports submitted per year:

Claritin and Midol drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 21.0% - (5 of 23 people)
  • 1 - 6 months: 18.0% - (2 of 11 people)
  • 6 - 12 months: 40.0% - (2 of 5 people)
  • 1 - 2 years: 33.0% - (4 of 12 people)
  • 2 - 5 years: 73.0% - (14 of 19 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 80.0% - (4 of 5 people)
  • not specified: 0.0% - (0 of 2 people)
Midol:
  • < 1 month: 40.0% - (11 of 27 people)
  • 1 - 6 months: 37.0% - (3 of 8 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 28.0% - (2 of 7 people)
  • 2 - 5 years: 36.0% - (4 of 11 people)
  • 5 - 10 years: 50.0% - (4 of 8 people)
  • 10+ years: 25.0% - (3 of 12 people)
  • not specified: 75.0% - (3 of 4 people)

Drug effectiveness by gender:

Claritin:
  • female: 43.0% - (25 of 58 people)
  • male: 33.0% - (7 of 21 people)
Midol:
  • female: 37.0% - (23 of 61 people)
  • male: 42.0% - (8 of 19 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 5 people)
  • 10-19: 0.0% - (0 of 4 people)
  • 20-29: 33.0% - (3 of 9 people)
  • 30-39: 38.0% - (5 of 13 people)
  • 40-49: 47.0% - (10 of 21 people)
  • 50-59: 52.0% - (9 of 17 people)
  • 60+: 55.0% - (5 of 9 people)
Midol:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 25.0% - (1 of 4 people)
  • 10-19: 50.0% - (2 of 4 people)
  • 20-29: 60.0% - (6 of 10 people)
  • 30-39: 42.0% - (6 of 14 people)
  • 40-49: 25.0% - (5 of 20 people)
  • 50-59: 33.0% - (6 of 18 people)
  • 60+: 55.0% - (5 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • drug ineffective
  • chills
  • completed suicide
  • headache
  • pyrexia
  • somnolence
  • vomiting
  • palpitations
  • urticaria
  • anxiety
1 - 6 months:
  • nausea
  • anhedonia
  • anxiety
  • emotional distress
  • general physical health deterioration
  • injury
  • abdominal pain lower
  • cardiac arrest
  • diarrhoea
  • disease progression
6 - 12 months:
  • cognitive disorder
  • emotional distress
  • hallucination, olfactory
  • hyperphagia
  • hypersexuality
  • impulse-control disorder
  • injury
  • major depression
  • pathological gambling
  • psychotic disorder
1 - 2 years:
  • dyspnoea
  • fatigue
  • chest pain
  • heart pounding or racing
  • teeth grinding and clenching
  • temperature regulation disorder
  • tremor
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • pulmonary embolism
  • abdominal distension
2 - 5 years:
  • chest pain
  • anxiety
  • depression
  • anaemia postoperative
  • angina pectoris
  • back pain
  • cerebral infarction
  • cerebrovascular disorder
  • coronary artery disease
  • exhaustion, fatigue, lethargy, tiredness, weariness
5 - 10 years:
  • anxiety
  • depression
  • electrocardiogram qt prolonged
  • injury
  • nightmare
  • pain
  • pulmonary embolism
  • emotional distress
  • general physical health deterioration
  • renal failure
10+ years:
  • pain
  • pulmonary embolism
  • anxiety
  • deep vein thrombosis
  • emotional distress
  • injury
  • abdominal pain upper
  • dyskinesia
  • emotional disorder
  • acid reflux
not specified:
  • nausea
  • pain
  • fatigue
  • headache
  • anxiety
  • dyspnoea
  • dizziness
  • depression
  • vomiting
  • back pain

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • anxiety
  • headache
  • dyspnoea
  • fatigue
  • back pain
  • pulmonary embolism
  • depression
  • vomiting
male:
  • fatigue
  • headache
  • nausea
  • dyspnoea
  • pain
  • depression
  • vomiting
  • dizziness
  • pyrexia
  • chest pain

Most common drug interactions by age *:

0-1:
  • ankyloglossia congenital
  • croup infectious
  • diarrhoea
  • ear infection
  • gait disturbance
  • jaundice neonatal
  • plagiocephaly
  • sinusitis
  • torticollis
  • upper respiratory tract infection
2-9:
  • vomiting
  • pyrexia
  • throat irritation
  • sinusitis
  • sudden death
  • viral infection
  • status epilepticus
  • abdominal pain
  • arrhythmia
  • drug ineffective
10-19:
  • anxiety
  • headache
  • pain
  • cholelithiasis
  • dyspnoea
  • chest pain
  • crohn's disease
  • colitis
  • depression
  • inflammatory bowel disease
20-29:
  • pain
  • emotional distress
  • anxiety
  • cholecystitis chronic
  • nausea
  • deep vein thrombosis
  • pulmonary embolism
  • cholelithiasis
  • injury
  • abdominal pain upper
30-39:
  • pain
  • pulmonary embolism
  • anxiety
  • injury
  • nausea
  • deep vein thrombosis
  • emotional distress
  • dyspnoea
  • depression
  • headache
40-49:
  • fatigue
  • nausea
  • headache
  • pain
  • dyspnoea
  • anxiety
  • cough
  • pain in extremity
  • arthralgia
  • depression
50-59:
  • nausea
  • fatigue
  • back pain
  • headache
  • pain
  • dizziness
  • asthenia
  • vomiting
  • chest pain
  • pyrexia
60+:
  • nausea
  • dizziness
  • dyspnoea
  • fatigue
  • diarrhoea
  • headache
  • asthenia
  • drug ineffective
  • hypertension
  • pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Midol?

Can you answer these questions?

More questions for: Claritin, Midol

You may be interested in these reviews

More reviews for: Claritin, Midol

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Midol (ibuprofen) is often used to treat dysmenorrhoea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.